BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1417902)

  • 1. Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin.
    Slomiany BL; Liau YH; Lopez RA; Piotrowski J; Czajkowski A; Slomiany A
    Biochem Int; 1992 Aug; 27(4):687-97. PubMed ID: 1417902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of gastric sulfomucin.
    Liau YH; Lopez RA; Slomiany A; Slomiany BL
    Biochem Biophys Res Commun; 1992 May; 184(3):1411-7. PubMed ID: 1590801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of sulfation in the processing of gastric mucins.
    Liau YH; Murty VL; Slomiany A; Bielanski W; Slomiany BL
    J Physiol Pharmacol; 1991 Dec; 42(4):357-66. PubMed ID: 1726711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Dec; 31(6):1051-8. PubMed ID: 7514919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.
    Piotrowski J
    J Physiol Pharmacol; 1998 Mar; 49(1):3-24. PubMed ID: 9594407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.
    Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 Jun; 27(1):131-8. PubMed ID: 1385705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and secretion of gastric sulfomucin in the presence of ebrotidine, a new antiulcer agent.
    Slomiany BL; Lopez RA; Slomiany A
    Biochem Int; 1992 Dec; 28(4):665-74. PubMed ID: 1482403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori lipopolysaccharide inhibits acid secretion in pylorus-ligated conscious rats.
    Ootsubo C; Okumura T; Takahashi N; Wakebe H; Imagawa K; Kikuchi M; Kohgo Y
    Biochem Biophys Res Commun; 1997 Jul; 236(2):532-7. PubMed ID: 9240475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor.
    Piotrowski J; Majka J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1995 Jul; 36(3):491-8. PubMed ID: 7549946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosulfatase activity of H. pylori toward human gastric mucin: effect of sucralfate.
    Slomiany BL; Murty VL; Piotrowski J; Grabska M; Slomiany A
    Am J Gastroenterol; 1992 Sep; 87(9):1132-7. PubMed ID: 1381553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor mediates Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis.
    Slomiany BL; Slomiany A
    IUBMB Life; 2004 Jan; 56(1):41-6. PubMed ID: 14992379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of sucralfate.
    Piotrowski J; Yamaki K; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1991 Dec; 86(12):1756-60. PubMed ID: 1835819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
    Slomiany BL; Piotrowski J; Slomiany A
    J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL; Piotrowski J; Slomiany A
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Helicobacter pylori colonization by sulfated gastric mucin.
    Piotrowski J; Slomiany A; Murty VL; Fekete Z; Slomiany BL
    Biochem Int; 1991 Jul; 24(4):749-56. PubMed ID: 1799374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Lopez RA; Liau YH; Slomiany A
    Gen Pharmacol; 1993 May; 24(3):611-7. PubMed ID: 8365641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impedance of Helicobacter pylori lipopolysaccharide interference with gastric mucin synthesis by peroxisome proliferator-activated receptor gamma activation involves phosphatidylinositol 3-kinase/ERK pathway.
    Slomiany BL; Slomiany A
    IUBMB Life; 2003 Feb; 55(2):97-102. PubMed ID: 12749691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.